company_name,location,website,therapeutic_areas,fit_score,reason_for_fit,num_decision_makers,num_phase2_failed,num_phase3_failed,num_drug_assets
Celmatix,"New York City, New York, United States",https://www.celmatix.com,"women's health, fertility",70,"Celmatix's focus on women's health, specifically PCOS and infertility, aligns with Convexia's interest in rescuing failed or dormant assets in these areas. Although specific failed trials or dormant assets are not identified, the company's therapeutic focus and preclinical stage suggest potential for future rescue opportunities.",5,0,0,0
Spruce Biosciences,"San Francisco, California, United States",https://www.sprucebiosciences.com,"endocrinology, women's health",70,"Spruce Biosciences has a clear focus on endocrine disorders, including PCOS, with a drug in clinical trials. Despite the lack of detailed outcomes, the scientific rationale and therapeutic focus align with Convexia's interest in rescuing failed or dormant assets.",5,0,0,1
